Comparative analysis of biophysical methods for monitoring protein proximity induction in the development of small molecule degraders

Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1867; no. 9; p. 130398
Main Authors Przytulski, Kamil, Glaza, Przemyslaw, Brach, Katarzyna, Sagan, Maria, Statkiewicz, Grzegorz, Klajn, Jan, Walczak, Michal J.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2023
Subjects
Online AccessGet full text
ISSN0304-4165
1872-8006
1872-8006
DOI10.1016/j.bbagen.2023.130398

Cover

Abstract Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches. The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach. We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay. The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay. The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody. [Display omitted] •Biophysical proximity assays allow monitoring formation of ternary complex.•Protein labeling based on peptide tag derived from bacterial adhesin is described.•LinkScape-based TR-FRET enables detection of protein proximity induced by degraders.•AlphaLISA lacks information about exact stoichiometry between assay components.
AbstractList Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches. The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach. We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay. The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay. The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody.
Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches. The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach. We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay. The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay. The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody. [Display omitted] •Biophysical proximity assays allow monitoring formation of ternary complex.•Protein labeling based on peptide tag derived from bacterial adhesin is described.•LinkScape-based TR-FRET enables detection of protein proximity induced by degraders.•AlphaLISA lacks information about exact stoichiometry between assay components.
Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches.BACKGROUNDTargeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the latter. Biophysical methods allow the measurement of the ternary complex formation by recombinant target and E3 ligase proteins in the presence of molecular glues and bifunctional degraders. The development of new chemotypes of degraders mediating ternary complex formation of unknown dimensions and geometries requires the use of different biophysical approaches.The TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach.METHODSThe TR-FRET and AlphaLISA platforms have been applied to study molecular glues and bifunctional degraders. The performance of the label-based proximity assays was compared with the BLI method, which is a label-free, sensor-based approach.We present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay.RESULTSWe present and compare two commonly used assays to monitor proximity induction, AlphaLISA and TR-FRET. The LinkScape system consisting of the CaptorBait peptide and the CaptorPrey protein is a novel method of protein labeling compatible with TR-FRET assay.The TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay.CONCLUSIONSThe TR-FRET and AlphaLISA proximity assays enable detection of ternary complexes formed between an E3 Ligase, a target protein and a small molecule degrader. Experiments with different chemotypes of GSPT1 degraders showed that ALphaLISA was more susceptible to chemotype-dependent interference than TR-FRET assay.The discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody.GENERAL SIGNIFICANCEThe discovery and optimization of small-molecule inducers of ternary complexes is greatly accelerated by using biophysical assays. The LinkScape-based TR-FRET assay is an alternative to antibody-based proximity assays due to the CaptorPrey's subnanomolar affinity to the CaptorBait-tagged protein target, and the 10-fold lower molecular weight of the CaptorPrey protein compared to the antibody.
ArticleNumber 130398
Author Statkiewicz, Grzegorz
Walczak, Michal J.
Brach, Katarzyna
Klajn, Jan
Przytulski, Kamil
Sagan, Maria
Glaza, Przemyslaw
Author_xml – sequence: 1
  givenname: Kamil
  surname: Przytulski
  fullname: Przytulski, Kamil
  email: k.przytulski@captortherapeutics.com
  organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland
– sequence: 2
  givenname: Przemyslaw
  surname: Glaza
  fullname: Glaza, Przemyslaw
  email: p.glaza@captortherapeutics.com
  organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland
– sequence: 3
  givenname: Katarzyna
  surname: Brach
  fullname: Brach, Katarzyna
  email: k.brach@captortherapeutics.com
  organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland
– sequence: 4
  givenname: Maria
  surname: Sagan
  fullname: Sagan, Maria
  email: m.sagan@captortherapeutics.com
  organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland
– sequence: 5
  givenname: Grzegorz
  surname: Statkiewicz
  fullname: Statkiewicz, Grzegorz
  email: g.statkiewicz@captortherapeutics.com
  organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland
– sequence: 6
  givenname: Jan
  surname: Klajn
  fullname: Klajn, Jan
  email: j.klajn@captortherapeutics.com
  organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland
– sequence: 7
  givenname: Michal J.
  surname: Walczak
  fullname: Walczak, Michal J.
  email: michal.walczak@captortherapeutics.com
  organization: Captor Therapeutics Inc, Duńska St 11, PL54427 Wroclaw, Poland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37301332$$D View this record in MEDLINE/PubMed
BookMark eNqFUcGO0zAQtdAitrvwBwj5yCVlEiepwwEJVcCutBIXOFuOPWldOXawnWr7Afw3jrJw4ABzmbH83tPMezfkynmHhLwuYVtC2b47bfteHtBtK6jYtmTAOv6MbEq-qwoO0F6RDTCoi7psm2tyE-MJcjVd84Jcsx2DkrFqQ37u_TjJIJM5I5VO2ks0kfqB9sZPx_xQ0tIR09HrSAcf6OidST4Yd6BT8AmNW_qjGU26UOP0rJLxLk80HZFqPKP104guLaJxlDbLeYtqtsvvIUiNIb4kzwdpI7566rfk--dP3_Z3xcPXL_f7jw-FYm2VinYYOMcmH8QZclCNrvlQaw5Vo0DBTjHdtazLZyqQrRzqst8BZz1oLQfsO3ZL3q66eeUfM8YkRhMVWisd-jmKild120HLIUPfPEHnfkQtpmBGGS7it3UZUK8AFXyMAYc_kBLEkpA4iTUhsSQk1oQy7f1fNGWSXDxLQRr7P_KHlYzZpLPBIKIy6BRqE1Alob35t8AvXNuxJw
CitedBy_id crossref_primary_10_1016_j_bioorg_2024_107868
crossref_primary_10_1002_cbic_202400193
crossref_primary_10_1080_17460441_2023_2275640
Cites_doi 10.1021/acsptsci.0c00122
10.1038/nature14610
10.1126/science.1177319
10.1016/j.ab.2004.05.055
10.1074/jbc.RA118.002702
10.1038/s41573-021-00371-6
10.1038/s41573-021-00245-x
10.1177/108705719900400206
10.1016/j.molcel.2017.06.004
10.7554/eLife.38430
10.1111/j.1472-8206.2008.00633.x
10.1038/s41589-018-0055-y
10.1021/acschembio.9b00092
10.1016/0734-9750(94)90292-5
10.1073/pnas.141230798
10.1089/adt.2009.9996
10.1177/108705710200700102
10.1073/pnas.1814446115
10.1038/s41573-019-0047-y
10.1021/acs.jmedchem.1c00895
10.1016/j.bmcl.2008.07.114
10.1074/jbc.RA120.014715
10.1021/ja311795d
10.1038/nature16979
10.1126/science.aab1433
10.1038/nature18611
10.1016/j.jchromb.2004.01.017
10.1038/nature13527
10.1016/j.ddtec.2019.01.002
10.1021/acsptsci.1c00032
10.1182/blood.2020008676
ContentType Journal Article
Copyright 2023 Elsevier B.V.
Copyright © 2023 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2023 Elsevier B.V.
– notice: Copyright © 2023 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1016/j.bbagen.2023.130398
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
ExternalDocumentID 37301332
10_1016_j_bbagen_2023_130398
S030441652300096X
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
NPM
7X8
ACLOT
EFKBS
~HD
ID FETCH-LOGICAL-c362t-6ff88e516583e80c5d48f4d8025c0c07c3d9639000c0a6af41b7083b0ddafeb93
IEDL.DBID AIKHN
ISSN 0304-4165
1872-8006
IngestDate Sat Sep 27 18:06:29 EDT 2025
Wed Feb 19 02:24:23 EST 2025
Tue Jul 01 00:22:18 EDT 2025
Thu Apr 24 22:57:25 EDT 2025
Fri Feb 23 02:36:04 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Molecular glue
Bifunctional degrader
Targeted protein degradation
TR-FRET
Ternary complex formation
Protein labeling
Language English
License Copyright © 2023 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c362t-6ff88e516583e80c5d48f4d8025c0c07c3d9639000c0a6af41b7083b0ddafeb93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 37301332
PQID 2824690680
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2824690680
pubmed_primary_37301332
crossref_primary_10_1016_j_bbagen_2023_130398
crossref_citationtrail_10_1016_j_bbagen_2023_130398
elsevier_sciencedirect_doi_10_1016_j_bbagen_2023_130398
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2023
2023-09-00
2023-Sep
20230901
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: September 2023
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta. General subjects
PublicationTitleAlternate Biochim Biophys Acta Gen Subj
PublicationYear 2023
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Dong, Ding, He, Sheng (bb0010) 2021; 64
Békés, Langley, Crews (bb0015) 2022; 21
Nowak, Deangelo, Buckley, He, Donovan, An, Safaee, Jedrychowski, Ponthier, Ishoey, Zhang, Mancias, Gray, Bradner, Fischer (bb0085) 2018; 14
Schneekloth, Pucheault, Tae, Crews (bb0030) 2008; 18
Fischer (bb0130) 1994; 12
Schapira, Calabrese, Bullock, Crews (bb0005) 2019; 18
Guhathakurta, Prochniewicz, Grant, Peterson, Thomas (bb0075) 2018; 293
Matyskiela, Lu, Ito, Pagarigan, Lu, Miller, Fang, Wang, Nguyen, Houston, Carmel, Tran, Riley, Nosaka, Lander, Gaidarova, Xu, Ruchelman, Handa, Carmichael, Daniel, Cathers, Lopez-Girona, Chamberlain (bb0050) 2016; 535
Surka, Jin, Mbong, Lu, Jang, Rychak, Mendy, Clayton, Tindall, Hsu, Fontanillo, Tran, Contreras, Ng, Matyskiela, Wang, Chamberlain, Cathers, Carmichael, Hansen, Wang, Minden, Fan, Pierce, Pourdehnad, Rolfe, Lopez-Girona, Dick, Lu (bb0105) 2021; 137
Schasfoort (bb0200) 2017
Donovan, An, Nowak, Yuan, Fink, Berry, Ebert, Fischer (bb0065) 2018; 7
Bahmanyar, Calabrese, CASHION, Cathers, CORREA, DELGADO, Hansen, Hegde, Huang, Leftheris (bb0115) 2015
Lin, Williams, Murray, Conn, Ropp (bb0125) 2004; 803
Roy, Winkler, Hughes, Whitworth, Galant, Farnaby, Rumpel, Ciulli (bb0195) 2019; 14
(bb0180) 2022
Han (bb0150) 2020; 295
Markossian, Grossman, Brimacombe (bb0160) 2004
Sakamoto, Kim, Kumagai, Mercurio, Crews, Deshaies (bb0025) 2001; 98
Chan, Erdman, Fung, Hecht, Lam, Sullivan, Torres (bb0110) 2022
Goutelle, Maurin, Rougier, Barbaut, Bourguignon, Ducher, Maire (bb0155) 2008; 22
Ito, Ando, Suzuki, Ogura, Hotta, Imamura, Yamaguchi, Handa (bb0040) 2010; 327
Gorshkov, Chen, Xu, Carlos De La Torre, Martinez-Sobrido, Moran, Zheng (bb0080) 2020; 3
Gemechu, Millrine, Hashimoto, Prakash, Sanchenkova, Metwally, Gyanu, Kang, Kishimoto (bb0120) 2018; 115
Winter, Buckley, Paulk, Roberts, Souza, Dhe-Paganon, Bradner (bb0090) 2015; 348
Bosse, Illy, Chelsky (bb0185) 2002
Lakowicz (bb0170) 2006
Petzold, Fischer, Thomä (bb0055) 2016; 532
Schneider, Radoux, Hercules, Ochoa, Dunham, Zalmas, Hessler, Ruf, Shanmugasundaram, Hann, Thomas, Queisser, Benowitz, Brown, Leach (bb0020) 2021; 20
Lenz (bb0035) 1966; 112
Glickman, Wu, Mercuri, Illy, Bowen, He, Sills (bb0070) 2002; 7
Zhang, Chung, Oldenburg (bb0165) 1999; 4
Krönke, Fink, Hollenbach, MacBeth, Hurst, Udeshi, Chamberlain, Mani, Man, Gandhi, Svinkina, Schneider, McConkey, Järås, Griffiths, Wetzler, Bullinger, Cathers, Carr, Chopra, Ebert (bb0060) 2015; 523
Lin, Chen (bb0100) 2021
Nikolovska-Coleska, Wang, Fang, Pan, Tomita, Li, Roller, Krajewski, Saito, Stuckey, Wang (bb0140) 2004; 332
Peleg, Prabahar, Bednarczyk, Unger (bb0135) 2017; 1586
Fischer, Böhm, Lydeard, Yang, Stadler, Cavadini, Nagel, Serluca, Acker, Lingaraju, Tichkule, Schebesta, Forrester, Schirle, Hassiepen, Ottl, Hild, Beckwith, Harper, Jenkins, Thomä (bb0045) 2014; 512
Pettersson, Crews (bb0175) 2019; 31
Bielefeld-Sevigny (bb0190) 2009; 7
Winter, Mayer, Buckley, Erb, Roderick, Vittori, Reyes, di Iulio, Souza, Ott, Roberts, Zeid, Scott, Paulk, Lachance, Olson, Dastjerdi, Bauer, Lin, Gray, Kelliher, Churchman, Bradner (bb0095) 2017; 67
Douglass, Miller, Sparer, Shapiro, Spiegel (bb0145) 2013; 135
Schapira (10.1016/j.bbagen.2023.130398_bb0005) 2019; 18
Gemechu (10.1016/j.bbagen.2023.130398_bb0120) 2018; 115
Schasfoort (10.1016/j.bbagen.2023.130398_bb0200) 2017
Sakamoto (10.1016/j.bbagen.2023.130398_bb0025) 2001; 98
Pettersson (10.1016/j.bbagen.2023.130398_bb0175) 2019; 31
Schneekloth (10.1016/j.bbagen.2023.130398_bb0030) 2008; 18
Bosse (10.1016/j.bbagen.2023.130398_bb0185) 2002
Peleg (10.1016/j.bbagen.2023.130398_bb0135) 2017; 1586
Lakowicz (10.1016/j.bbagen.2023.130398_bb0170) 2006
Fischer (10.1016/j.bbagen.2023.130398_bb0045) 2014; 512
Goutelle (10.1016/j.bbagen.2023.130398_bb0155) 2008; 22
Matyskiela (10.1016/j.bbagen.2023.130398_bb0050) 2016; 535
Surka (10.1016/j.bbagen.2023.130398_bb0105) 2021; 137
Dong (10.1016/j.bbagen.2023.130398_bb0010) 2021; 64
Zhang (10.1016/j.bbagen.2023.130398_bb0165) 1999; 4
Winter (10.1016/j.bbagen.2023.130398_bb0090) 2015; 348
Gorshkov (10.1016/j.bbagen.2023.130398_bb0080) 2020; 3
Lin (10.1016/j.bbagen.2023.130398_bb0125) 2004; 803
Roy (10.1016/j.bbagen.2023.130398_bb0195) 2019; 14
Guhathakurta (10.1016/j.bbagen.2023.130398_bb0075) 2018; 293
Chan (10.1016/j.bbagen.2023.130398_bb0110) 2022
Han (10.1016/j.bbagen.2023.130398_bb0150) 2020; 295
Donovan (10.1016/j.bbagen.2023.130398_bb0065) 2018; 7
Nowak (10.1016/j.bbagen.2023.130398_bb0085) 2018; 14
Fischer (10.1016/j.bbagen.2023.130398_bb0130) 1994; 12
Bahmanyar (10.1016/j.bbagen.2023.130398_bb0115)
Bielefeld-Sevigny (10.1016/j.bbagen.2023.130398_bb0190) 2009; 7
Winter (10.1016/j.bbagen.2023.130398_bb0095) 2017; 67
Markossian (10.1016/j.bbagen.2023.130398_bb0160) 2004
Lenz (10.1016/j.bbagen.2023.130398_bb0035) 1966; 112
Krönke (10.1016/j.bbagen.2023.130398_bb0060) 2015; 523
Nikolovska-Coleska (10.1016/j.bbagen.2023.130398_bb0140) 2004; 332
Békés (10.1016/j.bbagen.2023.130398_bb0015) 2022; 21
Ito (10.1016/j.bbagen.2023.130398_bb0040) 2010; 327
Glickman (10.1016/j.bbagen.2023.130398_bb0070) 2002; 7
Schneider (10.1016/j.bbagen.2023.130398_bb0020) 2021; 20
Lin (10.1016/j.bbagen.2023.130398_bb0100) 2021
Douglass (10.1016/j.bbagen.2023.130398_bb0145) 2013; 135
Petzold (10.1016/j.bbagen.2023.130398_bb0055) 2016; 532
References_xml – volume: 7
  start-page: 90
  year: 2009
  end-page: 92
  ident: bb0190
  article-title: AlphaLISA immunoassay platform- the “no-Wash” high-throughput alternative to ELISA
  publication-title: Assay Drug Dev. Technol.
– volume: 22
  start-page: 633
  year: 2008
  end-page: 648
  ident: bb0155
  article-title: The hill equation: a review of its capabilities in pharmacological modelling
  publication-title: Fundam. Clin. Pharmacol.
– volume: 7
  year: 2018
  ident: bb0065
  article-title: Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome
  publication-title: Elife.
– volume: 1586
  start-page: 33
  year: 2017
  end-page: 43
  ident: bb0135
  article-title: Heterologous Gene Expression in E.coli
– start-page: 1
  year: 2017
  end-page: 26
  ident: bb0200
  article-title: Introduction to surface plasmon resonance
  publication-title: Handb. Surf. Plasmon Reson., (2), The Royal Society of Chemistry
– volume: 14
  start-page: 361
  year: 2019
  end-page: 368
  ident: bb0195
  article-title: SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate
  publication-title: ACS Chem. Biol.
– year: 2022
  ident: bb0110
  article-title: Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applications, (2022) Biotheryx Inc. Publication Number: WO/2020/242960. International Application Number: PCT/US2020/034264
– year: 2002
  ident: bb0185
  article-title: Principles of AlphaScreen, Amplified Luminescent Proximity Homogenous Assay, AlphaScreen Appl. Note
– volume: 532
  start-page: 127
  year: 2016
  end-page: 130
  ident: bb0055
  article-title: Structural basis of lenalidomide-induced CK1α degradation by the CRL4 CRBN ubiquitin ligase
  publication-title: Nature.
– year: 2006
  ident: bb0170
  article-title: Principles of Fluorescence Spectroscopy
– volume: 115
  start-page: 11802
  year: 2018
  end-page: 11807
  ident: bb0120
  article-title: Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 512
  start-page: 49
  year: 2014
  end-page: 53
  ident: bb0045
  article-title: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide
  publication-title: Nature.
– volume: 7
  start-page: 3
  year: 2002
  end-page: 10
  ident: bb0070
  article-title: A comparison of ALPHAscreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors
  publication-title: J. Biomol. Screen.
– volume: 4
  start-page: 67
  year: 1999
  end-page: 73
  ident: bb0165
  article-title: A simple statistical parameter for use in evaluation and validation of high throughput screening assays
  publication-title: J. Biomol. Screen.
– volume: 14
  start-page: 706
  year: 2018
  end-page: 714
  ident: bb0085
  article-title: Plasticity in binding confers selectivity in ligand-induced protein degradation article
  publication-title: Nat. Chem. Biol.
– year: 2021
  ident: bb0100
  article-title: General stepwise approach to optimize a TR-FRET assay for characterizing the BRD/PROTAC/CRBN ternary complex
  publication-title: ACS Pharmacol. Transl. Sci.
– volume: 332
  start-page: 261
  year: 2004
  end-page: 273
  ident: bb0140
  article-title: Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization
  publication-title: Anal. Biochem.
– volume: 18
  start-page: 5904
  year: 2008
  end-page: 5908
  ident: bb0030
  article-title: Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics, bioorganic med
  publication-title: Chem. Lett.
– volume: 64
  start-page: 10606
  year: 2021
  end-page: 10620
  ident: bb0010
  article-title: Molecular glues for targeted protein degradation: from serendipity to rational discovery
  publication-title: J. Med. Chem.
– volume: 20
  start-page: 789
  year: 2021
  end-page: 797
  ident: bb0020
  article-title: The PROTACtable genome
  publication-title: Nat. Rev. Drug Discov.
– volume: 12
  start-page: 89
  year: 1994
  end-page: 101
  ident: bb0130
  article-title: Renaturation of recombinant proteins produced as inclusion bodies
  publication-title: Biotechnol. Adv.
– volume: 803
  start-page: 353
  year: 2004
  end-page: 362
  ident: bb0125
  article-title: Ion chromatographic quantification of cyanate in urea solutions: estimation of the efficiency of cyanate scavengers for use in recombinant protein manufacturing
  publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci.
– volume: 295
  start-page: 15280
  year: 2020
  end-page: 15291
  ident: bb0150
  article-title: A suite of mathematical solutions to describe ternary complex formation and their application to targeted protein degradation by heterobifunctional ligands
  publication-title: J. Biol. Chem.
– volume: 31
  start-page: 15
  year: 2019
  end-page: 27
  ident: bb0175
  article-title: PROteolysis TArgeting chimeras (PROTACs) — past, present and future
  publication-title: Drug Discov. Today Technol.
– volume: 98
  start-page: 8554
  year: 2001
  end-page: 8559
  ident: bb0025
  article-title: Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 67
  start-page: 5
  year: 2017
  end-page: 18.e19
  ident: bb0095
  article-title: BET Bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment
  publication-title: Mol. Cell
– year: 2022
  ident: bb0180
  article-title: Prism 9 Curve Fitting guide, Equation: Bell-shaped dose-response
– volume: 21
  start-page: 181
  year: 2022
  end-page: 200
  ident: bb0015
  article-title: PROTAC targeted protein degraders: the past is prologue
  publication-title: Nat. Rev. Drug Discov.
– volume: 523
  start-page: 183
  year: 2015
  end-page: 188
  ident: bb0060
  article-title: Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
  publication-title: Nature.
– year: 2004
  ident: bb0160
  article-title: Assay Guidance Manual [Internet]
– volume: 535
  start-page: 252
  year: 2016
  end-page: 257
  ident: bb0050
  article-title: A novel cereblon modulator recruits GSPT1 to the CRL4 CRBN ubiquitin ligase
  publication-title: Nature.
– volume: 18
  start-page: 949
  year: 2019
  end-page: 963
  ident: bb0005
  article-title: Targeted protein degradation: expanding the toolbox
  publication-title: Nat. Rev. Drug Discov.
– volume: 293
  start-page: 12288
  year: 2018
  end-page: 12298
  ident: bb0075
  article-title: High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin–myosin structure and function
  publication-title: J. Biol. Chem.
– volume: 137
  start-page: 661
  year: 2021
  end-page: 677
  ident: bb0105
  article-title: CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells
  publication-title: Blood.
– volume: 135
  start-page: 6092
  year: 2013
  end-page: 6099
  ident: bb0145
  article-title: A comprehensive mathematical model for three-body binding equilibria
  publication-title: J. Am. Chem. Soc.
– year: 2015
  ident: bb0115
  article-title: Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith, (2020) Celgene Corp. Publication number: WO/2020/243379
– volume: 112
  start-page: 99
  year: 1966
  end-page: 106
  ident: bb0035
  article-title: Malformations caused by drugs in pregnancy
  publication-title: Am. J. Dis. Child.
– volume: 327
  start-page: 1345
  year: 2010
  end-page: 1350
  ident: bb0040
  article-title: Identification of a primary target of thalidomide teratogenicity
  publication-title: Science (80-.)
– volume: 3
  start-page: 1233
  year: 2020
  end-page: 1241
  ident: bb0080
  article-title: Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 nucleocapsid
  publication-title: ACS Pharmacol. Transl. Sci.
– volume: 348
  start-page: 1376
  year: 2015
  end-page: 1381
  ident: bb0090
  article-title: Phthalimide conjugation as a strategy for in vivo target protein degradation
  publication-title: Science (80-.)
– volume: 3
  start-page: 1233
  year: 2020
  ident: 10.1016/j.bbagen.2023.130398_bb0080
  article-title: Development of a high-throughput homogeneous AlphaLISA drug screening assay for the detection of SARS-CoV-2 nucleocapsid
  publication-title: ACS Pharmacol. Transl. Sci.
  doi: 10.1021/acsptsci.0c00122
– volume: 1586
  start-page: 33
  year: 2017
  ident: 10.1016/j.bbagen.2023.130398_bb0135
– volume: 523
  start-page: 183
  year: 2015
  ident: 10.1016/j.bbagen.2023.130398_bb0060
  article-title: Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
  publication-title: Nature.
  doi: 10.1038/nature14610
– year: 2004
  ident: 10.1016/j.bbagen.2023.130398_bb0160
– volume: 327
  start-page: 1345
  year: 2010
  ident: 10.1016/j.bbagen.2023.130398_bb0040
  article-title: Identification of a primary target of thalidomide teratogenicity
  publication-title: Science (80-.)
  doi: 10.1126/science.1177319
– start-page: 1
  year: 2017
  ident: 10.1016/j.bbagen.2023.130398_bb0200
  article-title: Introduction to surface plasmon resonance
– year: 2022
  ident: 10.1016/j.bbagen.2023.130398_bb0110
– ident: 10.1016/j.bbagen.2023.130398_bb0115
– volume: 332
  start-page: 261
  year: 2004
  ident: 10.1016/j.bbagen.2023.130398_bb0140
  article-title: Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2004.05.055
– volume: 293
  start-page: 12288
  year: 2018
  ident: 10.1016/j.bbagen.2023.130398_bb0075
  article-title: High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin–myosin structure and function
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.RA118.002702
– volume: 21
  start-page: 181
  year: 2022
  ident: 10.1016/j.bbagen.2023.130398_bb0015
  article-title: PROTAC targeted protein degraders: the past is prologue
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-021-00371-6
– volume: 20
  start-page: 789
  year: 2021
  ident: 10.1016/j.bbagen.2023.130398_bb0020
  article-title: The PROTACtable genome
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-021-00245-x
– volume: 4
  start-page: 67
  year: 1999
  ident: 10.1016/j.bbagen.2023.130398_bb0165
  article-title: A simple statistical parameter for use in evaluation and validation of high throughput screening assays
  publication-title: J. Biomol. Screen.
  doi: 10.1177/108705719900400206
– volume: 67
  start-page: 5
  year: 2017
  ident: 10.1016/j.bbagen.2023.130398_bb0095
  article-title: BET Bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2017.06.004
– volume: 7
  year: 2018
  ident: 10.1016/j.bbagen.2023.130398_bb0065
  article-title: Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane radial ray syndrome
  publication-title: Elife.
  doi: 10.7554/eLife.38430
– volume: 22
  start-page: 633
  year: 2008
  ident: 10.1016/j.bbagen.2023.130398_bb0155
  article-title: The hill equation: a review of its capabilities in pharmacological modelling
  publication-title: Fundam. Clin. Pharmacol.
  doi: 10.1111/j.1472-8206.2008.00633.x
– volume: 14
  start-page: 706
  year: 2018
  ident: 10.1016/j.bbagen.2023.130398_bb0085
  article-title: Plasticity in binding confers selectivity in ligand-induced protein degradation article
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/s41589-018-0055-y
– year: 2002
  ident: 10.1016/j.bbagen.2023.130398_bb0185
– volume: 14
  start-page: 361
  year: 2019
  ident: 10.1016/j.bbagen.2023.130398_bb0195
  article-title: SPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate
  publication-title: ACS Chem. Biol.
  doi: 10.1021/acschembio.9b00092
– volume: 12
  start-page: 89
  year: 1994
  ident: 10.1016/j.bbagen.2023.130398_bb0130
  article-title: Renaturation of recombinant proteins produced as inclusion bodies
  publication-title: Biotechnol. Adv.
  doi: 10.1016/0734-9750(94)90292-5
– volume: 98
  start-page: 8554
  year: 2001
  ident: 10.1016/j.bbagen.2023.130398_bb0025
  article-title: Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.141230798
– volume: 7
  start-page: 90
  year: 2009
  ident: 10.1016/j.bbagen.2023.130398_bb0190
  article-title: AlphaLISA immunoassay platform- the “no-Wash” high-throughput alternative to ELISA
  publication-title: Assay Drug Dev. Technol.
  doi: 10.1089/adt.2009.9996
– volume: 7
  start-page: 3
  year: 2002
  ident: 10.1016/j.bbagen.2023.130398_bb0070
  article-title: A comparison of ALPHAscreen, TR-FRET, and TRF as assay methods for FXR nuclear receptors
  publication-title: J. Biomol. Screen.
  doi: 10.1177/108705710200700102
– volume: 115
  start-page: 11802
  year: 2018
  ident: 10.1016/j.bbagen.2023.130398_bb0120
  article-title: Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.1814446115
– volume: 18
  start-page: 949
  year: 2019
  ident: 10.1016/j.bbagen.2023.130398_bb0005
  article-title: Targeted protein degradation: expanding the toolbox
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-019-0047-y
– volume: 64
  start-page: 10606
  year: 2021
  ident: 10.1016/j.bbagen.2023.130398_bb0010
  article-title: Molecular glues for targeted protein degradation: from serendipity to rational discovery
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.1c00895
– volume: 18
  start-page: 5904
  year: 2008
  ident: 10.1016/j.bbagen.2023.130398_bb0030
  article-title: Targeted intracellular protein degradation induced by a small molecule: en route to chemical proteomics, bioorganic med
  publication-title: Chem. Lett.
  doi: 10.1016/j.bmcl.2008.07.114
– year: 2006
  ident: 10.1016/j.bbagen.2023.130398_bb0170
– volume: 295
  start-page: 15280
  year: 2020
  ident: 10.1016/j.bbagen.2023.130398_bb0150
  article-title: A suite of mathematical solutions to describe ternary complex formation and their application to targeted protein degradation by heterobifunctional ligands
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.RA120.014715
– volume: 135
  start-page: 6092
  year: 2013
  ident: 10.1016/j.bbagen.2023.130398_bb0145
  article-title: A comprehensive mathematical model for three-body binding equilibria
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja311795d
– volume: 112
  start-page: 99
  year: 1966
  ident: 10.1016/j.bbagen.2023.130398_bb0035
  article-title: Malformations caused by drugs in pregnancy
  publication-title: Am. J. Dis. Child.
– volume: 532
  start-page: 127
  year: 2016
  ident: 10.1016/j.bbagen.2023.130398_bb0055
  article-title: Structural basis of lenalidomide-induced CK1α degradation by the CRL4 CRBN ubiquitin ligase
  publication-title: Nature.
  doi: 10.1038/nature16979
– volume: 348
  start-page: 1376
  year: 2015
  ident: 10.1016/j.bbagen.2023.130398_bb0090
  article-title: Phthalimide conjugation as a strategy for in vivo target protein degradation
  publication-title: Science (80-.)
  doi: 10.1126/science.aab1433
– volume: 535
  start-page: 252
  year: 2016
  ident: 10.1016/j.bbagen.2023.130398_bb0050
  article-title: A novel cereblon modulator recruits GSPT1 to the CRL4 CRBN ubiquitin ligase
  publication-title: Nature.
  doi: 10.1038/nature18611
– volume: 803
  start-page: 353
  year: 2004
  ident: 10.1016/j.bbagen.2023.130398_bb0125
  article-title: Ion chromatographic quantification of cyanate in urea solutions: estimation of the efficiency of cyanate scavengers for use in recombinant protein manufacturing
  publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci.
  doi: 10.1016/j.jchromb.2004.01.017
– volume: 512
  start-page: 49
  year: 2014
  ident: 10.1016/j.bbagen.2023.130398_bb0045
  article-title: Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide
  publication-title: Nature.
  doi: 10.1038/nature13527
– volume: 31
  start-page: 15
  year: 2019
  ident: 10.1016/j.bbagen.2023.130398_bb0175
  article-title: PROteolysis TArgeting chimeras (PROTACs) — past, present and future
  publication-title: Drug Discov. Today Technol.
  doi: 10.1016/j.ddtec.2019.01.002
– year: 2021
  ident: 10.1016/j.bbagen.2023.130398_bb0100
  article-title: General stepwise approach to optimize a TR-FRET assay for characterizing the BRD/PROTAC/CRBN ternary complex
  publication-title: ACS Pharmacol. Transl. Sci.
  doi: 10.1021/acsptsci.1c00032
– volume: 137
  start-page: 661
  year: 2021
  ident: 10.1016/j.bbagen.2023.130398_bb0105
  article-title: CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells
  publication-title: Blood.
  doi: 10.1182/blood.2020008676
SSID ssj0000595
Score 2.4321368
Snippet Targeted protein degradation relies on inducing proximity between an E3 ubiquitin ligase and a target protein, and subsequent proteasomal degradation of the...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 130398
SubjectTerms Bifunctional degrader
Molecular glue
Protein labeling
Targeted protein degradation
Ternary complex formation
TR-FRET
Title Comparative analysis of biophysical methods for monitoring protein proximity induction in the development of small molecule degraders
URI https://dx.doi.org/10.1016/j.bbagen.2023.130398
https://www.ncbi.nlm.nih.gov/pubmed/37301332
https://www.proquest.com/docview/2824690680
Volume 1867
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1872-8006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000595
  issn: 0304-4165
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Complete Freedom Collection [SCCMFC]
  customDbUrl:
  eissn: 1872-8006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000595
  issn: 0304-4165
  databaseCode: ACRLP
  dateStart: 19950118
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection
  customDbUrl:
  eissn: 1872-8006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000595
  issn: 0304-4165
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1872-8006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000595
  issn: 0304-4165
  databaseCode: AIKHN
  dateStart: 19950118
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1872-8006
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000595
  issn: 0304-4165
  databaseCode: AKRWK
  dateStart: 19640113
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xUFUuiNIWFlpkJK7uJnEezhGtQNtW5dIi7c2KX9VWkF2xiwQXbvxvZmKHVQ8IiVMejh3LY898tsfzAZxY11SlySpeuVTyPPWC14nJuM2FqF2ambLzJvx1UY4v8x-TYrIGo_4sDLlVRt0fdHqnreObYWzN4Xw6Hf6mTT2EE7SsSUB8sg6bGVp7nIFtnn7_Ob5YKeSiI1-h7zll6E_QdW5eWuO4pUComSBmZFHLlyzUSwi0s0TnO7AdISQ7DbX8AGuu3YV3gVTyfhfej3oOt4_wOFoF92ZNjD_CZp7p6WweJcQCifSCIXxl190Qp7U-1kVwmLZ0vaNTUPcMp-8h1izeMQSOzK48jqjQxXVzhcUFwl1K_XvT-Ul_gsvzsz-jMY_EC9ygPVvy0nspXYFNJYWTiSlsLn1uJeIjk5ikMsLiuCW6UZM0ZePzVFcI5XRibeOdrsVn2GhnrdsHVmOiTRMtvHF5YwxOX3xemKLSxiB4EgMQfWMrE6OSEznGlerdz_6pICJFIlJBRAPgz7nmISrHK99XvRzVf71LoeF4JedxL3aFsqPdlKZ1s9uFwrkqLS2UMhnAXugPz3URpDeFyA7e_N9D2KKn4M32BTaWN7fuK8KfpT6C9W8P6VHs5E_g0gYQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RUEUvqNAWtg9wpV7dTWIncY5oVbTldSlIe7PiV7UIsit2kcqlt_7vzsQJKw4IiVOi-BHLMx5_tj_PAHxzvi4Lm5W89KniMg2CV4nNuJNCVD7NbNGyCc_Oi_GlPJ7kkzUY9XdhiFbZ2f5o01tr3X0Zdr05nE-nw190qIdwgrY1CYhPXsGGJI1Cpf7-d8XzQPyQx6MEySl7f3-uJXkZg6OW3KBmguIii0o9NT89hT_beejoLWx1AJIdxjZuw5pvduB1DCl5vwOboz6C2zv4N1q59mZ1532EzQIz09m8kw-LIaQXDMEru2kHOO30sdZ_w7Sh5x-6A3XPcPEePc3iG0PYyNyKb0SVLm7qa6wuhtul1N-3LUv6PVwe_bgYjXkXdoFbnM2WvAhBKZ9jVynhVWJzJ1WQTiE6solNSiscjloKNmqTuqiDTE2JQM4kztXBm0p8gPVm1vg9YBUmujQxIlgva2tx8RJkbvPSWIvQSQxA9J2tbeeTnEJjXOuefHalo4g0iUhHEQ2AP5SaR58cz-QveznqR7qlcdp4puTXXuwaZUdnKXXjZ3cLjStV2lgoVDKA3agPD20RZDWFyD6--L8HsDm-ODvVpz_PTz7BG0qJvLbPsL68vfNfEAgtzX6r6P8BHesG2w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparative+analysis+of+biophysical+methods+for+monitoring+protein+proximity+induction+in+the+development+of+small+molecule+degraders&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Przytulski%2C+Kamil&rft.au=Glaza%2C+Przemyslaw&rft.au=Brach%2C+Katarzyna&rft.au=Sagan%2C+Maria&rft.date=2023-09-01&rft.eissn=1872-8006&rft.volume=1867&rft.issue=9&rft.spage=130398&rft_id=info:doi/10.1016%2Fj.bbagen.2023.130398&rft_id=info%3Apmid%2F37301332&rft.externalDocID=37301332
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon